Skip to main content
. 2022 Oct 26;93(5):e2022305. doi: 10.23750/abm.v93i5.13668

Figure 2.

Figure 2.

A proposed treatment plan of the use of anti-osteoporotic drugs in β -Thalassemia major associated osteoporosis.

Legend: β-TM = β -Thalassemia major; BMD = bone mineral density; BPs = bisphosphonates; Zol = zoledronate; Dmab = denosumab.